Michael Scolaro

Michael Scolaro

Sep 10, 2017

Group 6 Copy 194
0
    Please wait...

    About This Project

    We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Dermatology AI Assistant to Empower Primary Care Providers in Zaatari Refugee Camp in Jordan

    An AI-assisted dermatology tool for refugees, utilizing imaging and symptom questionnaires to improve diagnostic...

    Thermal and Fluid Dynamical Effects on the Efficiency of Hyperpolarized Xenon Production

    The American Lung Association estimates that 32 million Americans are affected by lung diseases, many of...

    A novel approach to fight lung cancer progression

    We are working with a protein that modulates the genetic information to generate different proteins from...

    Backer Badge Funded